Oprah Winrey is on the cover of People magazine AGAIN! For decades the iconic talk show host and entertainment mogul has lived out her relationship with weight in public; from headline-making diet ...

n = number of patients included in each study group for HbA1c and body weight efficacy assessments Abbreviations: EOS: End of Study (week 16); Wk: week; BID: twice daily; CBD: cannabidiol; QD: once ...

Major Medicare and Medicaid changes are on their way now that the Centers for Medicare & Medicaid Services (CMS) has announced the new Better Approaches to Lifestyle and Nutrition for Comprehensive ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Next gen weight-loss medications are powerful — but eating too little can put some patients at serious nutritional risk.

Here’s the skinny on Chipotle’s new “GLP-1 friendly” menu. This coming Tuesday, Chipotle will debut its High Protein Menu –and it proves how weight-loss drugs such as Ozempic and Wegovy are altering ...

With GLP-1 use rising across the country, major brands are boosting protein, cutting sugar, and reworking formulations and packaging to fit how shoppers are eating today. Stacey Leasca is an ...

A growing body of research suggests that older adults are discontinuing GLP-1 medications at high rates, The New York Times reported Dec. 21. 2. Experts said stopping GLP-1 therapy often leads to ...

LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming ...

Stephen has degrees in science (Physics major) and arts (English Literature and the History and Philosophy of Science), as well as a Graduate Diploma in Science Communication. Stephen has degrees in ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through the courts. Thousands of patients have filed lawsuits claiming the makers of ...